Cargando…
Kamishoyosan and Shakuyakukanzoto promote recovery from paclitaxel-induced neurite retraction in PC12 cells
BACKGROUND: In chemotherapy, the full round of treatment must be completed as scheduled to achieve the strongest therapeutic effect. However, peripheral neuropathy, a severe side effect of the chemotherapeutic agent paclitaxel, can force the premature discontinuation of treatment. As some kampo prac...
Autores principales: | Konaka, Ken, Moriyama, Kota, Sakurada, Takumi, Okada, Naoto, Imanishi, Masaki, Zamami, Yoshito, Kawazoe, Kazuyoshi, Fushitani, Shuji, Ishizawa, Keisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521132/ https://www.ncbi.nlm.nih.gov/pubmed/28748102 http://dx.doi.org/10.1186/s40780-017-0090-y |
Ejemplares similares
-
Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study
por: Okada, Naoto, et al.
Publicado: (2020) -
A case of tetanus treated with Kampo medicines such as Kakkonto and Shakuyakukanzoto
por: Nakae, Hajime, et al.
Publicado: (2016) -
Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting database
por: Okada, Naoto, et al.
Publicado: (2018) -
A Case of Pseudohyperaldosteronism Induced by Yokukansan and Shakuyakukanzoto That Resulted in Severe Hypokalemia
por: Arai, Mika, et al.
Publicado: (2023) -
Clinical Experience of Use of Kampo Medicine Shakuyakukanzoto for Muscle Spasms Caused by Tetanus
por: Oshima, Kiyohiro, et al.
Publicado: (2023)